Robert Sorrell, MD
Orthopaedic Surgery · Vestavia, ALNPI 1205876927
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (41.9%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Prime Surgical, LLC at 42.1% of the total. Reporting peaked in 2019 at $3,344 and has fallen 80.8% since, to $643 in 2025.
Across 87 payments — averaging $107.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Prime Surgical, LLC$4K
- Endo Pharmaceuticals Inc.$2K
- Pacira Pharmaceuticals Incorporated$1K
- Zimmer Biomet$966
- Johnson & Johnson$605
- Orthalign Inc$147
- plus $675 from 21 others
Across 40 payments — averaging $3997.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biotissue Holdings Inc.$113K
- Endo Pharmaceuticals Inc.$20K
- Pacira Therapeutics, Inc.$16K
- Acadia Pharmaceuticals Inc$11K
What the payments were for
- Consulting fees$1,74019%
- Travel & lodging$1,29014%
- Food & beverage$2,38426%
- Education$3,90642%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Prime Surgical, LLC | 4 | $3,928 |
| Endo Pharmaceuticals Inc. | 1 | $1,740 |
| Pacira Pharmaceuticals Incorporated | 13 | $1,259 |
| Zimmer Biomet | 12 | $966 |
| Johnson & Johnson(2 entities) | 21 | $605 |
| Orthalign Inc | 1 | $147 |
| Pacira Therapeutics, Inc. | 5 | $95 |
| Bioventus LLC | 3 | $58 |
| Baxter Healthcare | 3 | $53 |
| Boston Scientific | 3 | $44 |
| Smith+Nephew | 1 | $44 |
| Convatec Inc. | 2 | $42 |
| Heraeus Medical, LLC. | 1 | $41 |
| Abbott | 2 | $38 |
| Ferring Pharmaceuticals Inc. | 2 | $33 |
| Si-bone, Inc. | 2 | $28 |
| Solventum Corporation | 1 | $28 |
| Fidia Pharma USA Inc. | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Vertex | 1 | $21 |
| Heron Therapeutics, Inc. | 1 | $18 |
| ERMI LLC | 1 | $17 |
| Kyowa Kirin, Inc. | 1 | $17 |
| Sanara Medtech Inc. | 1 | $15 |
| Baudax Bio Inc. | 1 | $15 |
| Orthofix Medical, Inc. | 1 | $14 |
| Zyla Life Sciences, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Zilretta$909
- Avenir$455
- Persona$349
- ORTHALIGN PLUS$147
- ROSA$120
How this compares
$9,320 in reported general payments places this provider in the 70th percentile of 319 orthopaedic surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $8,002 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 381 | $3,277 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 245 | $1,921 |
| Celecoxib | 101 | $1,721 |
| Meloxicam | 324 | $1,172 |
| Diclofenac Sodium | 64 | $892 |
| Methocarbamol | 72 | $698 |
| Gabapentin | 85 | $669 |
| Ondansetron Hcl | 56 | $544 |
| Methylprednisolone | 60 | $447 |
| Ibuprofen | 22 | $297 |
| Cyclobenzaprine Hcl | 22 | $273 |
| Ondansetron OdtOndansetron | 17 | $219 |
| Tizanidine Hcl | 26 | $206 |
| Naproxen | 11 | $137 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Vestavia
- Lawrence LemakVestavia$216K
- Scott AppellVestavia$30K
- Jeffrey DugasBirmingham$11.5M
- Benton EmblomBirmingham$3M
- Herrick SiegelBirmingham$1.2M
- Paul CanaleDaphne$609K
- Kenneth MooreBirmingham$342K
- Joseph SherrillBirmingham$221K
- Jonathan QuadeBirmingham$217K
- Ginger BryantBirmingham$209K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.